Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first p

RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United S

Bristol Myers Squibb trades at a steeper discount despite higher leverage, while Novo Nordisk comman

The market made a modest gain - but most stocks got left behind.

John Moolenaar asks the US Defense Department to add 58 Chinese schools and 62 technology labs to it

Have Moderna's shares risen too much, too fast?

A new NIH-backed initiative to speed up personalized cancer vaccine development sent stocks like MRN

Vaccine and biotechnology names are leading a sharp sector rally, and a small protein-vaccine develo

Cantor Fitzgerald just bumped price targets on Eli Lilly, AbbVie, Merck, and Pfizer, but higher targ

GAMMA Investing LLC lifted its stake in Merck and Co., Inc. (NYSE: MRK) by 5.8% in the undefined qua

Apella Capital LLC grew its position in shares of Merck and Co., Inc. (NYSE: MRK) by 16.6% in the un

Farther Finance Advisors LLC boosted its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 9.

Halozyme wins a Dutch court order blocking Merck's Keytruda SC in eight European markets, strengthen

Investors looking for stocks in the Large Cap Pharmaceuticals sector might want to consider either I

Three sectors are higher and eight are lower in Thursday's regular session, with the top three s

On October 7, three companies with nothing in common sent cash to their shareholders, but the differ

Three stocks left the S&P 500's 2025 return in the dust, but gains that large raise one uncomfortabl

Cantor Fitzgerald analyst Carter Gould maintains Merck & Co (NYSE:MRK) with a Neutral and rai

Tempus Inc. (NASDAQ:TEM) on Wednesday expanded its multi-year collaboration for intismeran autogene

Tempus AI expands its collaboration with Moderna and Merck to support sample collection and NGS serv

A Dutch court rules in favor of Halozyme Therapeutics, barring Merck from selling subcutaneous Keytr

Morgan Stanley analyst Terence Flynn maintains Merck & Co (NYSE:MRK) with a Overweight and lo

Merck (MRK) reached $141.94 at the closing of the latest trading day, reflecting a +1.72% change com

Merck's 7% dip may offer a buying opportunity as Keytruda drives growth and new products and pipelin

Vaccine stocks are trending on Tuesday. Shares of Moderna Inc. (NASDAQ:MRNA), Vaxcyte Inc. (NASDA

Park National Corp OH trimmed its stake in Merck and Co., Inc. (NYSE: MRK) by 6.1% during the undefi

Rockland Trust Co. lowered its position in Merck and Co., Inc. (NYSE: MRK) by 6.5% in the undefined

Ferguson Wellman Capital Management Inc. lessened its holdings in shares of Merck and Co., Inc. (NYS

Eastern Bank increased its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 2.2% in the unde

Argent Capital Management LLC reduced its stake in shares of Merck and Co., Inc. (NYSE: MRK) by 5.1%

JP Morgan analyst Chris Schott maintains Merck & Co (NYSE:MRK) with a Overweight and raises t

Eight sectors are higher and three are lower in Monday's regular session, with growth, cyclical

Vaxcyte is poised to capture significant share of a $3 billion to $6 billion market following the la

Vaxcyte announced positive Phase 3 OPUS-1 trial results for its VAX-31 vaccine candidate, setting th

MassMutual Private Wealth and Trust FSB lessened its holdings in Merck and Co., Inc. (NYSE: MRK) by

Friday's regular session has eight sectors higher and three lower, with growth sectors holding t

Merck presented positive Phase 2b trial results for tulisokibart, demonstrating clear clinical effic

Moderna stock dips as Juan Andres returns as COO, Jerh Collins retires, and the company expands its

Results mark the first positive Phase 2 data for an anti-TL1A monoclonal antibody in dermatologyTuli

Scotiabank analyst Louise Chen maintains Merck & Co (NYSE:MRK) with a Sector Outperform and r

AstraZeneca invests $2 billion in Summit Therapeutics to combine cancer drugs ivonescimab and Sone-V

The Phase I clinical trial will evaluate a proprietary drug candidate formulated using Cyprumed’s or

Merck and Daiichi Sankyo voluntarily withdrew their FDA application for a lung cancer drug due to in

Merck (NYSE:MRK), known as MSD outside the United States and Canada, welcomes Ontario's decision

Under the agreement, SciBrunch has granted Merck exclusive rights to develop, manufacture and commer

Merck & Co (NYSE:MRK) has outperformed the market over the past 5 years by 3.0% on an annualized

The Biologics License Application (BLA) seeking accelerated approval in the U.S. for Daiichi Sankyo

AMD crossed $1 trillion and Meta's Muse rattled subscription stocks. Meanwhile, Treasury yields

 U.S. Food and Drug Administration (FDA) has approved the dual oral regimen of WELIREG® (belzutifan)

Moderna shares rose 0.09% after hours Thursday as investors eyed upcoming oncology data at a major E